INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
UNIVERSAL EYE DROPS (Solution)

SCHEDULING STATUS:
Not scheduled.

PROPRIETARY NAME
(and dosage form):

UNIVERSAL EYE DROPS (Solution)

COMPOSITION:
Each 1 mL contains:

Phenylephrine Hydrochloride		1,25 mg
Boric Acid		20,00 mg
Benzalkonium Chloride (preservative)		0,10 mg

PHARMACOLOGICAL CLASSIFICATION:
A 15.4 Ophthalmic preparations: Other.

PHARMACOLOGICAL ACTION:
Local vasoconstrictor and antiseptic.

INDICATIONS:
For the relief of eye strain, mild inflammation and allergic conjunctivitis.

CONTRA-INDICATIONS:
Hypersensitivity to any of the ingredients.
If any allergic reaction should occur, discontinue use and consult your doctor.

WARNINGS:

1.	Do not use for more than 30 days after first opening.
2.	As the possibility of adverse effects on the corneal permeability and the danger of disruption of the corneal epithelium with prolonged or repeated usage of benzalkonium chloride preserved ophthalmological preparations cannot be excluded, regular ophthalmological examination is required.
3.	Caution should be exercised in the use of benzalkonium chloride preserved topical medication over an extended period in patients with extensive ocular surface disease.

DOSAGE AND DIRECTIONS FOR USE:
Instil one or two drops into each eye, three or four times daily.

IDENTIFICATION:
Colourless Solution.

PRESENTATION:
15 mL Dropper Bottle.

STORAGE INSTRUCTIONS:
Store in a cool, dry place below 25°C and protect from light.
Keep out of reach of children.

REFERENCE NUMBER:
H1348 (Act 101/1965).

NAME AND BUSINESS ADDRESS OF APPLICANT:
Universal Pharmaceuticals (Pty) Ltd
7 Browning Street, Jeppe, Johannesburg.

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
7 February, 1975.

Code: UP51
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998